Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Olmesartan Medoxomil Related Compound A Pharmaceutical Secondary Standard, MilliporeSigma™ Supelco™

Catalog No. 111015681 Shop All MilliporeSigma Supelco Products
Change view
Click to view available options
Quantity:
40 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
11-101-5681 40 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 11-101-5681 Supplier MilliporeSigma Supelco Supplier No. PHR201640MG
Only null left
Add to Cart
Add to Cart
Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards. Olmesartan Medoxomil Related Compound A is found as an impurity of olmesartan medoxomil. Olmesartan medoxomil is a specific angiotensin II type 1 antagonist, which is widely used as an antihypertensive agent for the treatment of hypertension.
TRUSTED_SUSTAINABILITY

Specifications

CAS 849206-43-5
Purity Grade Notes These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.
Linear Formula C24H24N6O2
Synonym 3,6-Dihydro-6,6-dimethyl-2-propyl-3-[[2′-(2 H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-4 H-furo[3,4-d]imidazol-4-one; 1-{[2′-(1 H-Tetrazol-5-yl)biphenyl-4-yl]methyl}-4,4-dimethyl-2-propyl-1 H-furo[3,4-d]imidazol-6(4 H)-one
Type Certified Reference Material
Quantity 40 mg
Formula Weight 428.49
Grade Certified Reference Material
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.